Remote Behavioral Intervention Effective in Lowering Blood Pressure Variability

A new study reveals that remotely delivered behavioral interventions can effectively reduce systolic blood pressure variability, fostering better blood pressure control and reducing cardiovascular risks.
A recent study published in Scientific Reports has demonstrated that remotely delivered behavioral interventions can significantly reduce the variability of systolic blood pressure, known as the coefficient of variation (BPCoV). This research, conducted by Dr. Eyal Shemesh and colleagues from the Icahn School of Medicine at Mount Sinai in New York City, offers promising insights into managing blood pressure fluctuations through remote patient engagement.
The study involved a single-arm prospective proof-of-concept trial with patients exhibiting high blood pressure variability (BPCoV over 10%), identified through electronic health record reviews. Participants were provided with a blood pressure monitor and received behavioral interventions remotely over a three-month period. Out of 551 screened patients, 107 demonstrated high BPCoV, and 25 opted to participate in the intervention.
Results showed that the average BPCoV decreased from 12.96 in the six months prior to enrollment to 7.02 during the intervention, indicating a substantial reduction in blood pressure variability. Improvements were also noted across other variability measures, with data remaining consistent across different measurement methods, including clinic and home readings.
Dr. Shemesh emphasized the importance of monitoring blood pressure over time, rather than solely focusing on single-visit readings. The study highlights that remote engagement can effectively help patients stabilize their blood pressure, which is crucial for reducing cardiovascular risks associated with blood pressure fluctuations.
This innovative approach demonstrates that patients can be empowered to participate in their health management remotely, potentially transforming hypertension care. For more details, the full study can be accessed via source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Neural Implants in Tadpoles Provide Insights into Brain Development
Harvard researchers have developed flexible neural implants for tadpoles that enable real-time monitoring of brain development, opening new avenues for understanding neurodevelopmental disorders.
Premature Baby Celebrates First Birthday with Guinness World Record
Nash Keen, born at just 21 weeks and weighing only 10 ounces, has celebrated his first birthday, setting a Guinness World Record for the most premature baby to survive, showcasing advances in neonatal care.
Potential of Anti-Malarial Drugs in Promoting Weight Loss: New Research Findings
Research reveals that anti-malarial drugs like halofuginone may help promote weight loss by regulating appetite and energy metabolism through GDF15 and FGF21 pathways. This innovative approach, rooted in traditional Chinese medicine, offers promising new options for obesity treatment.



